Cytovance Biologics is a biopharmaceutical manufacturer operating on contract basis in the mammalian and microbial biologics. Recently, the firm made headlines with the announcement of their new Vice President in quality department.
Edwin Miranda was unveiled and is seen to take over the post. Edwin Miranda was the best-suited candidate for the post garnering over 3thirty years of experience when it comes to biopharmaceutical contract manufacturing in the industry.
Edwin Miranda is set to bring on board a wide range of experience in the quality assurance sector. Mr. Miranda is also set to impact the solid and liquid oral dose and also in terms of the biologics and cosmetics.
The firm is luck to harness a person of his standards with the experience to join the team. Edwin is set to become an asset to the firm with his background experiences, leadership skills, and knowledge.
Edwin Miranda has had past stints as a supervisor for the quality assurance for Keppra. As part of the quality assurance team, he pioneered for the successful FDA approval followed with the launch of the New Drug Application.
During his stay at URL Mutual Pharmaceuticals, he also served as the vice president and director of the quality assurance. Mr. Miranda has also held similar managerial positions at Piramal Critical Care and Legal Pharmaceutical Packaging.
The overall role Mr. Miranda played in all the firms includes the oversight of the regulatory compliance standards, management of the quality systems. Edwin Miranda was also involved in the development of successful remediation plans. This achieved enormous success such as the correction made for close to 500 observations. This was followed with the attainment of the good standing in the Establishing Inspection Report.
Away from his roles in quality assurance, Edwin Miranda is a graduate from the Angelo State University in San Angelo in Texas with a degree in Biology and Chemistry. Edwin Miranda has also had his fair share of service in the army.
To Know More Click Here